Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Metastatic Breast Cancer × Goserelin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 114 Breast Neoplasms 79 Neoplasms 6 Breast Neoplasms, Male 6 Neoplasm Metastasis 5 Salivary Gland Neoplasms 3 Advanced Breast Cancer 3 Recurrence 2 Prostate Adenocarcinoma 2 Osteoporosis 2 Leiomyoma 2 Infertility 2 Advanced Prostate Cancer 2 Triple Negative Breast Neoplasms 1 Stage I Prostate Adenocarcinoma AJCC v7 1 Sexual Dysfunction, Physiological 1 Primary Ovarian Insufficiency 1 Primary Dysautonomias 1 Patient Compliance 1 PSA Level Greater Than Two 1 Ovarian Neoplasms 1 Osteitis Deformans 1 Myofibroma 1 Lymphatic Metastasis 1 Kidney Diseases 1 Inflammatory Breast Neoplasms 1 Hypertension 1 Hyperlipidemias 1 Hot Flashes 1 Hormone-sensitive Metastatic Breast Cancer 1

Interventions

vistusertib 1 ribociclib 1 Tamoxifen 1 Letrozole 1 Goserelin 1 Fulvestrant 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02278120 2024-03-12

MONALEESA-7

Novartis

Phase 3 Completed

672 enrolled 16 charts 1 FDA

Advanced Metastatic Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡